Another rapid antigen test sponsor fined by the TGA An Australian company and two of its officers have also been ordered to pay $96,000 for the unlawful importation of surgical face masks.
Push to allow pharmacist prescribing of antivirals flipped on its head A ‘more sensible approach’ would see the lifesaving medications added to the Doctor’s Bag, a prominent GP has said.
Backing for mass mask handout in Victoria The RACGP President has lent her support to a Victorian Government initiative to supply millions of masks at key locations around the state.
ATAGI approves Moderna vaccine for at-risk young children Parents are advised not to contact vaccine providers until bookings open, following decision to approve vaccination for the youngest cohort.
Could anticipatory deprescribing allow better COVID treatment? Despite being more effective according to some studies, Paxlovid prescriptions lag Lagevrio, with drug–drug interactions likely to play a part.
Studies focus on COVID infectious period Early research suggests a quarter of people or more may still be infectious with COVID-19 after seven days, the standard isolation period across Australia.
Push to assess COVID-19 treatment eligibility prior to infection College launches new guidelines to support GPs assessing the best approach for vulnerable patients before they test positive.
COVID vaccine safety data for children ‘extremely reassuring’ A new study tracking nearly 400,000 children aged 5–15 post-vaccination found adverse events were generally short-term and mild.
Almost one in every two Australians has had COVID-19 Survey taken from blood donors in June confirms that levels have increased exponentially since a similar study in March.
TGA green lights Nuvaxovid for 12–17-year-olds But while provisional approval has been granted, inclusion in the national program for this age group is yet to be confirmed.